Gilead Sciences

Gilead Sciences is a biopharmaceutical company that focuses on developing and commercializing innovative drugs to address unmet medical needs in various therapeutic areas, including HIV, liver diseases, and inflammation. The company's product portfolio includes several marketed drugs, such as Truvada, Atripla, and Viread, as well as investigational drugs in various stages of clinical development. Gilead Sciences has a strong track record of innovation and has made significant investments in research and development to identify and develop new therapies for life-threatening diseases. The company has a global presence and operates in over 30 countries, with a focus on improving patient outcomes and advancing the field of medicine.